acyclovir
Generic: acyclovir
Labeler: chartwell rx, llcDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
chartwell rx, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
acyclovir 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
62135-039
Product ID
62135-039_458baf7d-dea5-aa22-e063-6394a90a8ae5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212173
Listing Expiration
2026-12-31
Marketing Start
2021-03-12
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
62135039
Hyphenated Format
62135-039
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA212173 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 50 CAPSULE in 1 BOTTLE (62135-039-50)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "458baf7d-dea5-aa22-e063-6394a90a8ae5", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "upc": ["0362135039509", "0362135019501"], "unii": ["X4HES1O11F"], "rxcui": ["197310", "197313"], "spl_set_id": ["8cd22728-34b4-4e55-8339-580138fe46d8"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 CAPSULE in 1 BOTTLE (62135-039-50)", "package_ndc": "62135-039-50", "marketing_start_date": "20220701"}], "brand_name": "Acyclovir", "product_id": "62135-039_458baf7d-dea5-aa22-e063-6394a90a8ae5", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "62135-039", "generic_name": "Acyclovir", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA212173", "marketing_category": "ANDA", "marketing_start_date": "20210312", "listing_expiration_date": "20261231"}